• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TELA Bio, Inc. - Common stock (NQ:TELA)

0.7000 +0.0500 (+7.69%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 124,083
Open 0.6680
Bid (Size) 0.6720 (1,800)
Ask (Size) 0.6860 (300)
Prev. Close 0.6500
Today's Range 0.6501 - 0.7000
52wk Range 0.5011 - 1.870
Shares Outstanding 39,388,443
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
TELA Bio (TELA) Q2 2026 Earnings Call Transcript ↗
August 19, 2026
Revenue declined 4% as OviTex PRS unit volumes fell, but international sales surged 26%. 
Via The Motley Fool
Topics Earnings World Trade
News headline image
TELA Bio Reports Second Quarter 2026 Financial Results
August 10, 2026
From TELA Bio, Inc.
Via GlobeNewswire

Performance

YTD
-38.6%
-38.6%
1 Month
-1.4%
-1.4%
3 Month
-22.2%
-22.2%
6 Month
-18.7%
-18.7%
1 Year
-60.7%
-60.7%

More News

Read More
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 05, 2026
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio (NASDAQ:TELA) Reports Mixed Q1 Results with Revenue Beat but Wider Loss and Cautious Q2 Guidance ↗
May 12, 2026
Via Chartmill
TELA Bio Inc (NASDAQ:TELA) Reports Record Q4 Revenue but Misses Sales Estimates ↗
March 24, 2026
Via Chartmill
News headline image
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
August 04, 2026
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
July 29, 2026
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Announce Second Quarter 2026 Financial Results
July 20, 2026
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
May 27, 2026
From Biotech Insider
Via GlobeNewswire
News headline image
TELA Bio Reports First Quarter 2026 Financial Results
May 12, 2026
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 07, 2026
From TELA Bio, Inc.
Via GlobeNewswire
Which stocks are moving on Friday? ↗
May 01, 2026
Via Chartmill
News headline image
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
April 30, 2026
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Announce First Quarter 2026 Financial Results
April 21, 2026
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Analysts Cut Their Forecasts After Q4 Results ↗
March 25, 2026
Via Benzinga
News headline image
TELA Bio (TELA) Q4 2025 Earnings Call Transcript ↗
March 24, 2026
Via The Motley Fool
Topics Earnings
News headline image
TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results
March 24, 2026
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results
March 10, 2026
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 20, 2026
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 23, 2026
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 12, 2025
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 19, 2025
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
Alphabet To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
November 18, 2025
Via Benzinga
News headline image
What's going on in today's after hours session ↗
November 17, 2025
Via Chartmill
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 17, 2025
From TELA Bio, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is TELA Bio, Inc. - Common stock publicly traded?
Yes, TELA Bio, Inc. - Common stock is publicly traded.
What exchange does TELA Bio, Inc. - Common stock trade on?
TELA Bio, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for TELA Bio, Inc. - Common stock?
The ticker symbol for TELA Bio, Inc. - Common stock is TELA on the Nasdaq Stock Market
What is the current price of TELA Bio, Inc. - Common stock?
The current price of TELA Bio, Inc. - Common stock is 0.7000
When was TELA Bio, Inc. - Common stock last traded?
The last trade of TELA Bio, Inc. - Common stock was at 08/28/26 04:00 PM ET
What is the market capitalization of TELA Bio, Inc. - Common stock?
The market capitalization of TELA Bio, Inc. - Common stock is 27.57M
How many shares of TELA Bio, Inc. - Common stock are outstanding?
TELA Bio, Inc. - Common stock has 28M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap